Cargando…
Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
SIMPLE SUMMARY: Treatment of hepatoblastoma at time of first diagnosis has evolved to include well described chemotherapy regimens along with surgical resection, resulting in improved outcomes. Unfortunately, in cases of recurrent or refractory disease, there is no standard of care to employ and the...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416880/ https://www.ncbi.nlm.nih.gov/pubmed/37568737 http://dx.doi.org/10.3390/cancers15153921 |